title: K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.
authors.affiliation: Department of Pharmacology, University of California, Davis, California 95616, USA. hwulff@ucdavis.edu
authors.forename: Heike
authors.initials: H
authors.lastname: Wulff
authors.forename: Boris S
authors.initials: BS
authors.lastname: Zhorov
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000378:metabolism*; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D015221:Potassium Channels / Q000737:chemistry / Q000378:metabolism*
chemical_list: D026902:Potassium Channel Blockers; D015221:Potassium Channels